We are live on
!
Find out more
VCM
Versant Capital Management Portfolio holdings
AUM
$1.12B
1-Year Est. Return
34.21%
This Fund
S&P 500
This Quarter
Est. Return
+13.52%
1 Year Est. Return
+34.21%
3 Year Est. Return
+82.39%
5 Year Est. Return
+89.4%
10 Year Est. Return
+245.39%
AUM
$1.12B
AUM Growth
+$101M
(+10%)
Cap. Flow
+$19.1M
Cap. Flow
% of AUM
1.71%
Top 10 Holdings %
Top 10 Hldgs %
31.56%
Holding
2,873
New
96
Increased
1,181
Reduced
859
Closed
128
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DXUV
Dimensional US Vector Equity ETF
DXUV
|
+$8.37M |
| 2 |
Dimensional Emerging Markets Core Equity 2 ETF
DFEM
|
+$7.66M |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$6.75M |
| 4 |
DXIV
Dimensional International Vector Equity ETF
DXIV
|
+$4.35M |
| 5 |
Dimensional Emerging Markets Value ETF
DFEV
|
+$2.47M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 3-7 Year Treasury Bond ETF
IEI
|
+$2.11M |
| 2 |
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
|
+$2.02M |
| 3 |
Vanguard Total Stock Market ETF
VTI
|
+$1.88M |
| 4 |
CoreCivic
CXW
|
+$1.84M |
| 5 |
Apple
AAPL
|
+$1.34M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.06% |
| 2 | Financials | 7.05% |
| 3 | Industrials | 6.04% |
| 4 | Consumer Discretionary | 4.74% |
| 5 | Healthcare | 4.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2176
Mitek Systems
MITK
$762M
| $11.8K | ﹤0.01% |
585
| – | – |
|
2177
Patria Investments
PAX
$1.72B
| $11.8K | ﹤0.01% |
1,072
| – | – |
|
2178
FirstCash
FCFS
$8.55B
| $11.7K | ﹤0.01% |
54
+36
| +200% | +$7.82K |
|
2179
Cedar Fair
FUN
$1.78B
| $11.7K | ﹤0.01% |
548
+522
| +2,008% | +$10.7K |
|
2180
Ethan Allen Interiors
ETD
$581M
| $11.6K | ﹤0.01% |
521
-670
| -56% | -$14.2K |
|
2181
Fastly Inc
FSLY
$3.17B
| $11.6K | ﹤0.01% |
632
| – | – |
|
2182
Kymera Therapeutics
KYMR
$9.1B
| $11.6K | ﹤0.01% |
101
+91
| +910% | +$7.82K |
|
2183
AeroVironment
AVAV
$7.57B
| $11.6K | ﹤0.01% |
70
-14
| -17% | -$2.51K |
|
2184
Alamo Group
ALG
$2.01B
| $11.5K | ﹤0.01% |
70
+31
| +79% | +$5.01K |
|
2185
Advance Auto Parts
AAP
$3.37B
| $11.5K | ﹤0.01% |
185
+159
| +612% | +$9.02K |
|
2186
Westamerica Bancorp
WABC
$1.39B
| $11.5K | ﹤0.01% |
196
| – | – |
|
2187
NETGEAR
NTGR
$669M
| $11.4K | ﹤0.01% |
490
+57
| +13% | +$1.42K |
|
2188
Levi Strauss
LEVI
$9.44B
| $11.4K | ﹤0.01% |
460
+329
| +251% | +$7.42K |
|
2189
Littelfuse
LFUS
$10.2B
| $11.4K | ﹤0.01% |
25
| – | – |
|
2190
iShares MSCI Global Metals & Mining Producers ETF
PICK
$2.19B
| $11.3K | ﹤0.01% |
195
+2
| +1% | +$125 |
|
|
EFC
2191
Ellington Financial
EFC
$1.68B
| $11.3K | ﹤0.01% |
831
| – | – |
|
2192
OrthoPediatrics
KIDS
$485M
| $11.3K | ﹤0.01% |
591
-582
| -50% | -$10.1K |
|
2193
Core Laboratories
CLB
$538M
| $11.3K | ﹤0.01% |
967
-285
| -23% | -$4.07K |
|
2194
Guardant Health
GH
$19.5B
| $11.3K | ﹤0.01% |
75
-22
| -23% | -$2.39K |
|
2195
LeMaitre Vascular
LMAT
$2.18B
| $11.2K | ﹤0.01% |
117
-49
| -30% | -$5.02K |
|
2196
CVR Energy
CVI
$3.36B
| $11.2K | ﹤0.01% |
407
| – | – |
|
2197
Enovix
ENVX
$862M
| $11.2K | ﹤0.01% |
1,846
| – | – |
|
2198
HNI Corp
HNI
$3B
| $11.2K | ﹤0.01% |
277
-378
| -58% | -$12.9K |
|
2199
Glaukos
GKOS
$9.02B
| $11.2K | ﹤0.01% |
80
+1
| +1% | +$127 |
|
2200
First Bank
FRBA
$451M
| $11.2K | ﹤0.01% |
629
-136
| -18% | -$2.19K |
|
Similar funds
FLAM
AIM
MTCM
CNC
NOSC
RIM
ACG
C
Versant Capital Management's Q2 2026 Portfolio in Review
As of Q2 2026, Versant Capital Management held 2,873 positions worth $1.12B, up 10% from $1.01B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Versant Capital Management's Q2 2026 filing shows 96 new, 1,181 increased, 859 reduced and 128 closed positions. Its largest new stake was AstraZeneca: 7,263 shares worth $1.36M. The largest sale was iShares 3-7 Year Treasury Bond ETF, an estimated $2.11M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Industrials.
- Versant Capital Management's largest Q2 2026 buy was AstraZeneca: 7,263 shares worth $1.36M.
- Versant Capital Management added most to Dimensional US Vector Equity ETF in Q2 2026, an estimated $8.37M increase.
- Versant Capital Management's biggest Q2 2026 reduction was iShares 3-7 Year Treasury Bond ETF, cutting an estimated $2.11M.
- Versant Capital Management fully exited iShares 5-10 Year Investment Grade Corporate Bond ETF in Q2 2026, selling an estimated $2.02M.
- Versant Capital Management's ten largest holdings make up 32% of its $1.12B portfolio in Q2 2026.
- Versant Capital Management opened 96 new positions and closed 128 in Q2 2026.
- Versant Capital Management's portfolio value rose 10% quarter-over-quarter to $1.12B.
Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.